Breaking News Instant updates and real-time market news.

SPB

Spectrum Brands

$84.91 /

+2.82 (+3.44%)

11:24
07/16/21
07/16
11:24
07/16/21
11:24

Sale of HHI unit could net $3.7B for Spectrum Brands, says Oppenheimer

After Bloomberg reported yesterday that Spectrum Brands was considering a potential sale of its Hardware and Home Improvement segment, Oppenheimer analyst Ian Zaffino said in a note to investors last night that that he estimates net proceeds for such a theoretical sale could approach $3.7B if the HHI unit were to command a mid-teens multiple. The analyst, who added that he thinks such a sale would be consistent with CEO David Maura's focus on value creation, keeps an Outperform rating on Spectrum Brands shares.

  • 03

    Aug

SPB Spectrum Brands
$84.91 /

+2.82 (+3.44%)

06/23/21 UBS
Spectrum Brands initiated with a Buy at UBS
05/10/21 Monness Crespi
Spectrum Brands price target raised to $113 from $100 at Monness Crespi
05/10/21 Wells Fargo
Spectrum Brands price target raised to $115 from $105 at Wells Fargo
05/10/21 Deutsche Bank
Spectrum Brands price target raised to $108 from $104 at Deutsche Bank

TODAY'S FREE FLY STORIES

Earnings
Digihost Technology reports Q3 EPS 1c vs. (5c) last year » 07:51
10/21/21
10/21
07:51
10/21/21
07:51
HSSHF

Digihost Technology

$1.86 /

+0.057 (+3.17%)

Reports Q3 revenue from…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HSSHF Digihost Technology
$1.86 /

+0.057 (+3.17%)

HSSHF Digihost Technology
$1.86 /

+0.057 (+3.17%)

06/01/21 H.C. Wainwright
Digihost Technology initiated with a Buy at H.C. Wainwright
HSSHF Digihost Technology
$1.86 /

+0.057 (+3.17%)

Initiation
William Blair starts Tempest Therapeutics with buy on oncology assets » 07:51
10/21/21
10/21
07:51
10/21/21
07:51
TPST

Tempest Therapeutics

$13.90 /

-0.08 (-0.57%)

William Blair analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TPST Tempest Therapeutics
$13.90 /

-0.08 (-0.57%)

TPST Tempest Therapeutics
$13.90 /

-0.08 (-0.57%)

06:11 Today William Blair
Tempest Therapeutics initiated with an Outperform at William Blair
07/13/21
Fly Intel: Top five analyst initiations
07/13/21 H.C. Wainwright
Tempest Therapeutics initiated with a Buy at H.C. Wainwright
07/06/21 Piper Sandler
Tempest Therapeutics initiated with an Overweight at Piper Sandler
TPST Tempest Therapeutics
$13.90 /

-0.08 (-0.57%)

TPST Tempest Therapeutics
$13.90 /

-0.08 (-0.57%)

Recommendations
Biogen price target lowered to $390 from $450 at Oppenheimer » 07:50
10/21/21
10/21
07:50
10/21/21
07:50
BIIB

Biogen

$266.28 /

-1.53 (-0.57%)

Oppenheimer analyst Jay…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BIIB Biogen
$266.28 /

-1.53 (-0.57%)

BIIB Biogen
$266.28 /

-1.53 (-0.57%)

07:37 Today Truist
Biogen price target lowered to $502 from $647 at Truist
06:54 Today Benchmark
Biogen, Roche calls 'not helpful for Ionis story,' says Benchmark
10/20/21 Piper Sandler
Biogen price target lowered to $390 from $460 at Piper Sandler
10/20/21 Piper Sandler
Biogen's Aduhelm launch 'even worse than feared,' says Piper Sandler
BIIB Biogen
$266.28 /

-1.53 (-0.57%)

BIIB Biogen
$266.28 /

-1.53 (-0.57%)

BIIB Biogen
$266.28 /

-1.53 (-0.57%)

BIIB Biogen
$266.28 /

-1.53 (-0.57%)

Recommendations
Abbott price target raised to $146 from $136 at Morgan Stanley » 07:50
10/21/21
10/21
07:50
10/21/21
07:50
ABT

Abbott

/

+

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ABT Abbott
/

+

ABT Abbott
/

+

07:34 Today Raymond James
Abbott price target raised to $134 from $128 at Raymond James
10/14/21 Redburn
Abbott initiated with a Neutral at Redburn
10/04/21 Cowen
Abbott Q3 results not likely to contain sales warning, says at Cowen
10/01/21 Citi
Abbott price target raised to $140 from $135 at Citi
ABT Abbott
/

+

ABT Abbott
/

+

ABT Abbott
/

+

ABT Abbott
/

+

Recommendations
Qualtrics price target raised to $48 from $39 at Loop Capital » 07:50
10/21/21
10/21
07:50
10/21/21
07:50
XM

Qualtrics

$44.25 /

+0.84 (+1.94%)

Loop Capital analyst Yun…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XM Qualtrics
$44.25 /

+0.84 (+1.94%)

XM Qualtrics
$44.25 /

+0.84 (+1.94%)

07:41 Today Canaccord
Qualtrics price target raised to $53 from $48 at Canaccord
07:38 Today Raymond James
Qualtrics price target raised to $55 from $45 at Raymond James
07:09 Today Deutsche Bank
Qualtrics price target raised to $48 from $45 at Deutsche Bank
06:51 Today BMO Capital
Qualtrics price target raised to $53 from $46 at BMO Capital
XM Qualtrics
$44.25 /

+0.84 (+1.94%)

  • 28
    Jan
XM Qualtrics
$44.25 /

+0.84 (+1.94%)

XM Qualtrics
$44.25 /

+0.84 (+1.94%)

XM Qualtrics
$44.25 /

+0.84 (+1.94%)

Hot Stocks
Draganfly commences drone pilot program at ASU » 07:49
10/21/21
10/21
07:49
10/21/21
07:49
DPRO

Draganfly

$3.56 /

-0.03 (-0.84%)

Draganfly announces that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DPRO Draganfly
$3.56 /

-0.03 (-0.84%)

DPRO Draganfly
$3.56 /

-0.03 (-0.84%)

09/27/21 ThinkEquity
Draganfly initiated with a Buy at ThinkEquity
  • 30
    Jul
DPRO Draganfly
$3.56 /

-0.03 (-0.84%)

Recommendations
Activision Blizzard price target lowered to $100 from $105 at Oppenheimer » 07:49
10/21/21
10/21
07:49
10/21/21
07:49
ATVI

Activision Blizzard

$78.06 /

+0.86 (+1.11%)

, AMZN

Amazon.com

$3,414.63 /

-28.62 (-0.83%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATVI Activision Blizzard
$78.06 /

+0.86 (+1.11%)

AMZN Amazon.com
$3,414.63 /

-28.62 (-0.83%)

ATVI Activision Blizzard
$78.06 /

+0.86 (+1.11%)

09/29/21 Jefferies
Jefferies still bullish on Activision Blizzard after analyzing 72 scenarios
09/15/21 KeyBanc
EA's delay of Battlefield 2042 slight positive for Activision, says KeyBanc
09/15/21 Benchmark
EA shares reacting negatively to Battlefield 2042 delay rumors, says Benchmark
09/15/21 Truist
Battlefield 2042 delay would be 'modest negative' for EA, says Truist
AMZN Amazon.com
$3,414.63 /

-28.62 (-0.83%)

10/20/21 Bernstein
Amazon.com may be more sheltered from broader sector declines, says Bernstein
10/13/21 Baird
Amazon.com weakness would be a buying opportunity, says Baird
10/12/21 JPMorgan
JPMorgan says Alphabet 'clearly the most liked' mega-cap internet stock
10/11/21 Loop Capital
Bed Bath & Beyond price target lowered to $14 from $18 at Loop Capital
ATVI Activision Blizzard
$78.06 /

+0.86 (+1.11%)

AMZN Amazon.com
$3,414.63 /

-28.62 (-0.83%)

ATVI Activision Blizzard
$78.06 /

+0.86 (+1.11%)

AMZN Amazon.com
$3,414.63 /

-28.62 (-0.83%)

ATVI Activision Blizzard
$78.06 /

+0.86 (+1.11%)

AMZN Amazon.com
$3,414.63 /

-28.62 (-0.83%)

ATVI Activision Blizzard
$78.06 /

+0.86 (+1.11%)

AMZN Amazon.com
$3,414.63 /

-28.62 (-0.83%)

Initiation
William Blair starts Jasper with buy on bone marrow transplant potential » 07:48
10/21/21
10/21
07:48
10/21/21
07:48
JSPR

Jasper Therapeutics

$14.02 /

+0.62 (+4.63%)

William Blair analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JSPR Jasper Therapeutics
$14.02 /

+0.62 (+4.63%)

JSPR Jasper Therapeutics
$14.02 /

+0.62 (+4.63%)

06:10 Today William Blair
Jasper Therapeutics initiated with an Outperform at William Blair
10/20/21
Fly Intel: Top five analyst initiations
10/20/21 BMO Capital
Jasper Therapeutics initiated with an Outperform at BMO Capital
10/12/21 Oppenheimer
Oppenheimer starts 'emerging leader' Jasper Therapeutics with Outperform
JSPR Jasper Therapeutics
$14.02 /

+0.62 (+4.63%)

Earnings
NeuroMetrix reports Q3 EPS (12c) vs. (7c) last year » 07:48
10/21/21
10/21
07:48
10/21/21
07:48
NURO

NeuroMetrix

$9.16 /

-0.14 (-1.51%)

Reports Q3 revenue $2.06M…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NURO NeuroMetrix
$9.16 /

-0.14 (-1.51%)

NURO NeuroMetrix
$9.16 /

-0.14 (-1.51%)

Recommendations
Tesla demonstrating value of data advantage, says Oppenheimer » 07:46
10/21/21
10/21
07:46
10/21/21
07:46
TSLA

Tesla

$865.75 /

+2.25 (+0.26%)

Oppenheimer analyst Colin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$865.75 /

+2.25 (+0.26%)

TSLA Tesla
$865.75 /

+2.25 (+0.26%)

07:45 Today Morgan Stanley
Shanghai plant, Model Y clearly positive for Tesla margins, says Morgan Stanley
07:39 Today Wells Fargo
Tesla price target raised to $860 from $660 at Wells Fargo
07:39 Today Canaccord
Tesla price target raised to $1040 from $940 at Canaccord
07:38 Today JPMorgan
Tesla 20M delivery target 'extreme blue sky scenario,' says JPMorgan
TSLA Tesla
$865.75 /

+2.25 (+0.26%)

TSLA Tesla
$865.75 /

+2.25 (+0.26%)

TSLA Tesla
$865.75 /

+2.25 (+0.26%)

TSLA Tesla
$865.75 /

+2.25 (+0.26%)

Hot Stocks
OpGen subsidiary Ares Genetics launches AREScloud » 07:46
10/21/21
10/21
07:46
10/21/21
07:46
OPGN

OpGen

$1.94 /

-0.05 (-2.51%)

OpGen announced that its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OPGN OpGen
$1.94 /

-0.05 (-2.51%)

OPGN OpGen
$1.94 /

-0.05 (-2.51%)

05/14/21 Alliance Global Partners
OpGen selloff in shares a buying opportunity, says Alliance Global Partners
03/02/21 Alliance Global Partners
Alliance Global raises OpGen price target to $7, sees 'eventful 2021'
11/13/20 Alliance Global Partners
OpGen price target raised to $5.65 from $5.00 at Alliance Global Partners
OPGN OpGen
$1.94 /

-0.05 (-2.51%)

OPGN OpGen
$1.94 /

-0.05 (-2.51%)

Earnings
Business First Bancshares reports Q3 adjusted EPS 53c, consensus 48c » 07:46
10/21/21
10/21
07:46
10/21/21
07:46
BFST

Business First Bancshares

$25.60 /

+0.365 (+1.45%)

Book value per common…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BFST Business First Bancshares
$25.60 /

+0.365 (+1.45%)

BFST Business First Bancshares
$25.60 /

+0.365 (+1.45%)

05/20/21 DA Davidson
Business First Bancshares upgraded to Buy from Neutral at DA Davidson
BFST Business First Bancshares
$25.60 /

+0.365 (+1.45%)

Recommendations
Shanghai plant, Model Y clearly positive for Tesla margins, says Morgan Stanley » 07:45
10/21/21
10/21
07:45
10/21/21
07:45
TSLA

Tesla

$865.75 /

+2.25 (+0.26%)

After Tesla (TSLA) posted…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$865.75 /

+2.25 (+0.26%)

TSLA Tesla
$865.75 /

+2.25 (+0.26%)

07:39 Today Wells Fargo
Tesla price target raised to $860 from $660 at Wells Fargo
07:39 Today Canaccord
Tesla price target raised to $1040 from $940 at Canaccord
07:38 Today JPMorgan
Tesla 20M delivery target 'extreme blue sky scenario,' says JPMorgan
07:32 Today Bernstein
Bernstein keeps Underperform rating on Tesla following 'solid' Q3 results
TSLA Tesla
$865.75 /

+2.25 (+0.26%)

TSLA Tesla
$865.75 /

+2.25 (+0.26%)

TSLA Tesla
$865.75 /

+2.25 (+0.26%)

TSLA Tesla
$865.75 /

+2.25 (+0.26%)

General news
Treasury Market Outlook: bonds and stocks are mostly lower » 07:45
10/21/21
10/21
07:45
10/21/21
07:45
$ECON

Economic Data

/

+

Treasury Market Outlook:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Earnings
American National Bankshares reports Q3 EPS 94c, consensus 81c » 07:44
10/21/21
10/21
07:44
10/21/21
07:44
AMNB

American National Bankshares

$34.87 /

+0.22 (+0.63%)

The Company continues to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMNB American National Bankshares
$34.87 /

+0.22 (+0.63%)

AMNB American National Bankshares
$34.87 /

+0.22 (+0.63%)

07/25/21 Keefe Bruyette
American National upgraded to Outperform from Market Perform at Keefe Bruyette
04/07/21 Raymond James
American National Bankshares downgraded to Market Perform from Outperform at Raymond James
AMNB American National Bankshares
$34.87 /

+0.22 (+0.63%)

Hot Stocks
Homology Medicines announces presentations across gene therapy programs » 07:44
10/21/21
10/21
07:44
10/21/21
07:44
FIXX

Homology Medicines

$6.08 /

-0.02 (-0.33%)

Homology Medicines…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FIXX Homology Medicines
$6.08 /

-0.02 (-0.33%)

FIXX Homology Medicines
$6.08 /

-0.02 (-0.33%)

09/07/21 Oppenheimer
BioMarin clinical hold has little read through to Homology, says Oppenheimer
05/18/21 Canaccord
Homology Medicines price target lowered to $19 from $37 at Canaccord
05/07/21 Oppenheimer
Homology Medicines price target lowered to $24 from $27 at Oppenheimer
04/28/21 Stifel
Protalix, Sanofi updates may signal headwinds for Avrobio, Amicus, says Stifel
FIXX Homology Medicines
$6.08 /

-0.02 (-0.33%)

  • 07
    Apr
Recommendations
Lam Research price target lowered to $575 from $660 at Wells Fargo » 07:44
10/21/21
10/21
07:44
10/21/21
07:44
LRCX

Lam Research

$566.24 /

-3.95 (-0.69%)

Wells Fargo analyst Joe…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LRCX Lam Research
$566.24 /

-3.95 (-0.69%)

LRCX Lam Research
$566.24 /

-3.95 (-0.69%)

07:17 Today UBS
Lam Research price target lowered to $700 from $715 at UBS
07:12 Today Susquehanna
Lam Research price target lowered to $590 from $690 at Susquehanna
07:10 Today Deutsche Bank
Lam Research price target lowered to $650 from $700 at Deutsche Bank
06:46 Today Mizuho
Lam Research price target lowered to $700 from $725 at Mizuho
LRCX Lam Research
$566.24 /

-3.95 (-0.69%)

LRCX Lam Research
$566.24 /

-3.95 (-0.69%)

LRCX Lam Research
$566.24 /

-3.95 (-0.69%)

LRCX Lam Research
$566.24 /

-3.95 (-0.69%)

Hot Stocks
Cameco releases 2020 ESG report » 07:43
10/21/21
10/21
07:43
10/21/21
07:43
CCJ

Cameco

$26.88 /

+0.305 (+1.15%)

Cameco released its 2020…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CCJ Cameco
$26.88 /

+0.305 (+1.15%)

CCJ Cameco
$26.88 /

+0.305 (+1.15%)

10/12/21 Scotiabank
Cameco price target raised to C$35 from C$27 at Scotiabank
09/28/21 TD Securities
TD upgrades Cameco to Buy on uranium market rally
09/28/21 TD Securities
Cameco upgraded to Buy from Hold at TD Securities
09/23/21 Canaccord
Cameco price target raised to C$34 from C$27 at Canaccord
CCJ Cameco
$26.88 /

+0.305 (+1.15%)

CCJ Cameco
$26.88 /

+0.305 (+1.15%)

Recommendations
Cadence Design price target raised to $175 from $165 at Wells Fargo » 07:42
10/21/21
10/21
07:42
10/21/21
07:42
CDNS

Cadence Design

$159.98 /

+0.87 (+0.55%)

Wells Fargo analyst Gary…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CDNS Cadence Design
$159.98 /

+0.87 (+0.55%)

CDNS Cadence Design
$159.98 /

+0.87 (+0.55%)

10/20/21
Fly Intel: Top five analyst initiations
10/20/21 Needham
Cadence Design initiated with a Buy at Needham
10/19/21 Needham
Cadence Design initiated with a Buy at Needham
07/27/21 Baird
Cadence Design price target raised to $168 from $160 at Baird
CDNS Cadence Design
$159.98 /

+0.87 (+0.55%)

CDNS Cadence Design
$159.98 /

+0.87 (+0.55%)

Hot Stocks
PDS announces temporary suspension of recruitment in NCI-led Phase 2 trial » 07:41
10/21/21
10/21
07:41
10/21/21
07:41
PDSB

PDS Biotechnology

$12.00 /

-0.06 (-0.50%)

PDS Biotechnology…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PDSB PDS Biotechnology
$12.00 /

-0.06 (-0.50%)

PDSB PDS Biotechnology
$12.00 /

-0.06 (-0.50%)

08/12/21 H.C. Wainwright
PDS Biotechnology price target lowered to $15 from $20 at H.C. Wainwright
06/28/21 Cantor Fitzgerald
PDS Biotechnology initiated with an Overweight at Cantor Fitzgerald
06/09/21 Oppenheimer
PDS Biotechnology price target raised to $25 from $12 at Oppenheimer
06/09/21 Alliance Global Partners
PDS Biotechnology price target raised to $18 from $6.50 at Alliance Global Partners
PDSB PDS Biotechnology
$12.00 /

-0.06 (-0.50%)

  • 15
    Jun
PDSB PDS Biotechnology
$12.00 /

-0.06 (-0.50%)

Hot Stocks
First Wave BioPharma forms steering committee for Phase 2a PASSPORT trial » 07:41
10/21/21
10/21
07:41
10/21/21
07:41
FWBI

First Wave BioPharma

$2.97 /

+0.19 (+6.83%)

First Wave BioPharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FWBI First Wave BioPharma
$2.97 /

+0.19 (+6.83%)

Recommendations
Qualtrics price target raised to $53 from $48 at Canaccord » 07:41
10/21/21
10/21
07:41
10/21/21
07:41
XM

Qualtrics

$44.25 /

+0.84 (+1.94%)

Canaccord analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XM Qualtrics
$44.25 /

+0.84 (+1.94%)

XM Qualtrics
$44.25 /

+0.84 (+1.94%)

07:38 Today Raymond James
Qualtrics price target raised to $55 from $45 at Raymond James
07:09 Today Deutsche Bank
Qualtrics price target raised to $48 from $45 at Deutsche Bank
06:51 Today BMO Capital
Qualtrics price target raised to $53 from $46 at BMO Capital
06:20 Today JMP Securities
Qualtrics price target raised to $59 from $55 at JMP Securities
XM Qualtrics
$44.25 /

+0.84 (+1.94%)

  • 28
    Jan
XM Qualtrics
$44.25 /

+0.84 (+1.94%)

XM Qualtrics
$44.25 /

+0.84 (+1.94%)

XM Qualtrics
$44.25 /

+0.84 (+1.94%)

Hot Stocks
Hut 8 Mining purchases 12,000 new MicroBT Miners for $58.7M » 07:40
10/21/21
10/21
07:40
10/21/21
07:40
HUT

Hut 8 Mining

$12.35 /

+0.37 (+3.09%)

Hut 8 Mining has executed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HUT Hut 8 Mining
$12.35 /

+0.37 (+3.09%)

HUT Hut 8 Mining
$12.35 /

+0.37 (+3.09%)

10/14/21 DA Davidson
DA Davidson starts Hut 8 at Buy, names it top pick in bitcoin miner space
10/14/21 DA Davidson
Hut 8 Mining initiated with a Buy at DA Davidson
09/23/21 Canaccord
Hut 8 Mining initiated with a Buy at Canaccord
08/03/21 Craig-Hallum
Craig-Hallum bullish on Hut 8 Mining, initiates with a Buy
  • 15
    Sep
HUT Hut 8 Mining
$12.35 /

+0.37 (+3.09%)

HUT Hut 8 Mining
$12.35 /

+0.37 (+3.09%)

Hot Stocks
Gilead to present Biktarvy data, data from 43 other studies at AIDS Conference » 07:40
10/21/21
10/21
07:40
10/21/21
07:40
GILD

Gilead

$66.86 /

-0.03 (-0.04%)

Gilead announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GILD Gilead
$66.86 /

-0.03 (-0.04%)

GILD Gilead
$66.86 /

-0.03 (-0.04%)

10/19/21 Cowen
Gilead assumed with an Outperform at Cowen
09/23/21 Citi
Citi opens 'Positive Catalyst Watch' on Merck into Covid data
09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
07/30/21 BMO Capital
Gilead price target raised to $72 from $67 at BMO Capital
GILD Gilead
$66.86 /

-0.03 (-0.04%)

GILD Gilead
$66.86 /

-0.03 (-0.04%)

GILD Gilead
$66.86 /

-0.03 (-0.04%)

GILD Gilead
$66.86 /

-0.03 (-0.04%)

Recommendations
Tesla price target raised to $860 from $660 at Wells Fargo » 07:39
10/21/21
10/21
07:39
10/21/21
07:39
TSLA

Tesla

$865.75 /

+2.25 (+0.26%)

Wells Fargo analyst Colin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$865.75 /

+2.25 (+0.26%)

TSLA Tesla
$865.75 /

+2.25 (+0.26%)

07:39 Today Canaccord
Tesla price target raised to $1040 from $940 at Canaccord
07:38 Today JPMorgan
Tesla 20M delivery target 'extreme blue sky scenario,' says JPMorgan
07:32 Today Bernstein
Bernstein keeps Underperform rating on Tesla following 'solid' Q3 results
07:06 Today Deutsche Bank
Tesla price target raised to $1,000 from $900 at Deutsche Bank
TSLA Tesla
$865.75 /

+2.25 (+0.26%)

TSLA Tesla
$865.75 /

+2.25 (+0.26%)

TSLA Tesla
$865.75 /

+2.25 (+0.26%)

TSLA Tesla
$865.75 /

+2.25 (+0.26%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.